The central role of JAK2/BCR-ABL protein complex was demonstrated to stabilize BCR-ABL kinase activity and interrupting this complex increased the clearance of BCR-ABL+ cells, including CML stem/progenitor cells (116–118). Here, JAK2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.